Universität Wien

323005 VO Preclinical Drug Development - MPS4 (2021W)

7.00 ECTS (3.00 SWS), SPL 32 - Pharmazie
MIXED

Vorlesungstermine:
ONLINE
10.01.2022 14.00-17.00
11.01.2022 14.00-17.00
12.01.2022 14.00-17.00
13.01.2022 14.00-17.00
14.01.2022 14.00-17.00
17.01.2022 14.00-17.00
18.01.2022 14.00-17.00
19.01.2022 14.00-17.00
20.01.2022 14.00-17.00

Prüfungstermine:
27.01.2022 14.00-15.30 ONLINE
25.02.2022 09.00-10.30 ONLINE
11.03.2022 09.00-10.30 ONLINE

Registration/Deregistration

Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).

Details

Language: English

Examination dates

Lecturers

Classes

MPS4 will take place in January 2022, after the successful graduation of MPS1, MPS2 and MPS3.
10.01.; 11.01.; 12.01.; 13.01.; 14.01.; 17.01.; 18.01.; 19.01.; 20.01. 2-5 pm


Information

Aims, contents and method of the course

The students will be introduced to basic principles in preclinical drug development, consisting of three maintopics: Preclinical profiling, ADMET basic principles and synthetic methods in medicinal chemistry. The course will consist of presentations given by the faculty, as well as presentations given by students, followed by discussions rounds.

Assessment and permitted materials

There will be one oral evaluation at the end of the course. The grades will be deduced from the result in the oral evaluation.

Minimum requirements and assessment criteria

minimum 60% to pass

Examination topics

All topics covered during the course as well as the provided material on the moodle platform for MPS4.

Reading list


Association in the course directory

Last modified: Tu 19.10.2021 08:49